Disc Medicine (IRON) Stock Forecast & Price Target
Score
Disc Medicine, Inc. price target
| IRON | |
|---|---|
| Low | $92.00 |
| Average | $127.14 |
| High | $170.00 |
| Upside vs current price | +58.9% |
The average target of $127.14 is +58.9% versus the current IRON price of $80.00.
Disc Medicine, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 1 |
| Buy | 12 |
| Hold | 0 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
13 analysts cover IRON.
Disc Medicine, Inc. EPS and revenue estimates
IRON shows the next fiscal years with at least three analysts: 2026 EPS $-6.31, 2027 EPS $-6.63. A thinner year is left off this table.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $-6.31 | $3.16M |
| 2027 | $-6.63 | $32.65M |
Is Disc Medicine, Inc. a buy or sell?
Of the 13 analysts covering Disc Medicine, Inc., 13 rate it a buy (1 strong buy and 12 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The IRON consensus label is Buy, beside 13 buy-side ratings and 0 sell-side ratings.
The average target of $127.14 implies +58.9% versus the current price of $80.00.
Those 13 ratings on IRON are a headcount, and the label on file is Buy.
Reading the Disc Medicine, Inc. forecast
The IRON target range is wide: $92.00 at the low end, $127.14 in the middle, and $170.00 at the top.
Set next to the $80.00 IRON quote, that average is +58.9%.
Ratings on the Disc Medicine, Inc. cluster: 13 of 13 analysts are on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.
The average IRON target over the last month is $128.33, above the $119.40 average of the last quarter.
Only 13 analysts cover IRON, so the average rests on a short list.
Disc Medicine, Inc. forecast questions
What is the IRON price target?
The published range for IRON is $92.00 to $170.00, with an average of $127.14. That average is +58.9% versus the current price of $80.00.
Is Disc Medicine, Inc. a buy or sell?
Of the 13 analysts covering Disc Medicine, Inc., 13 rate it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the IRON headcount is 13 buy, 0 hold, and 0 sell.
What is the EPS estimate for Disc Medicine, Inc.?
Analyst EPS estimates for Disc Medicine, Inc.: 2026 $-6.31, 2027 $-6.63.
What is the revenue estimate for Disc Medicine, Inc.?
Analyst revenue estimates for Disc Medicine, Inc.: 2026 $3.16M, 2027 $32.65M.
How many analysts cover IRON?
13 analysts cover IRON. Their consensus on IRON is Buy, across those 13.